← Back to Search

Clinical Decision Support for Delirium

N/A
Recruiting
Led By Ira Hofer, MD
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up postoperative days 0-7
Awards & highlights

Study Summary

This trial will assess if a set of best practices can reduce cases of POD in people with cognitive impairment who undergo surgery. EHR data & CDS will be used.

Who is the study for?
This trial is for adult patients with cognitive impairment who are undergoing surgery at Mount Sinai Health System. It's also for the healthcare providers there receiving alerts during electronic health record system use. Patients can't join if it's not their first surgery since the study started, they lack documented cognitive impairment, or if the surgery is for organ donation.Check my eligibility
What is being tested?
The trial tests whether clinical decision support (CDS) prompts in electronic health records can reduce postoperative delirium (POD) in high-risk patients with cognitive issues. Half of these patients will receive usual care; the other half will get special alerts and best practice recommendations.See study design
What are the potential side effects?
Since this intervention involves information prompts rather than medications, traditional side effects aren't expected. However, there may be indirect effects on patient care based on how healthcare providers respond to these new CDS prompts.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~postoperative days 0-7
This trial's timeline: 3 weeks for screening, Varies for treatment, and postoperative days 0-7 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
4AT Delirium Score
Secondary outcome measures
Perioperative Best Practices proportion

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Clinical Decision SupportExperimental Treatment1 Intervention
Clinical decision support alerts in the electronic health record directed towards anesthesiologists caring for patients with preexisting cognitive impairment.
Group II: Standard of CareActive Control1 Intervention
No clinical decision support will appear, and standard of care procedures will take place.

Find a Location

Who is running the clinical trial?

Icahn School of Medicine at Mount SinaiLead Sponsor
861 Previous Clinical Trials
500,850 Total Patients Enrolled
University of California, Los AngelesOTHER
1,532 Previous Clinical Trials
10,240,842 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,675 Previous Clinical Trials
27,996,499 Total Patients Enrolled

Media Library

Clinical Decision Support Clinical Trial Eligibility Overview. Trial Name: NCT05777187 — N/A
Clinical Decision Support Systems Research Study Groups: Clinical Decision Support, Standard of Care
Clinical Decision Support Systems Clinical Trial 2023: Clinical Decision Support Highlights & Side Effects. Trial Name: NCT05777187 — N/A
Clinical Decision Support 2023 Treatment Timeline for Medical Study. Trial Name: NCT05777187 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any slots open for potential participants in this clinical trial?

"Unfortunately, this medical experiment is not presently recruiting. The trial was first published on June 15th 2023 and last modified on March 8th of the same year. Although no longer recruiting for applicants, there are currently 742 other clinical trials that require participants."

Answered by AI

May I be included in the ongoing research?

"This medical trial seeks 24426 participants who have been diagnosed with delirium and are between 18 and 120 years old."

Answered by AI

Are seniors aged 75 or younger able to partake in this clinical research?

"In accordance with the requirements of this clinical trial, eligible participants must be aged between 18 and 120."

Answered by AI
~6979 spots leftby Sep 2024